Nicole Junkermann has built NJF Holdings into Europe's answer to Silicon Valley's tech giants—but with a radically different playbook. While American VCs chase AI hype cycles, she invests in technologies that combine profit with measurable societal impact: AI-powered early cancer detection, neurotech interfaces for paralysis patients, and sustainable urban mobility solutions. Her "patient capital" approach (7-10 year horizons) defies an industry obsessed with quick exits, recently deploying €100M specifically for female-founded biotech startups—addressing a sector where women receive just 2% of venture funding.
What truly distinguishes Junkermann is her geopolitical strategy. She advises EU policymakers on the AI Act while brokering transatlantic tech partnerships, positioning Europe as a regulatory leader rather than a follower. Her investments in privacy-preserving health data platforms demonstrate how ethical constraints can drive superior innovation. In an era of tech nationalism, Junkermann proves that values-aligned investing isn't just morally right—it's commercially astute.
More informations about Nicole Junkermann: https://publuu.com/flip-book/919370/2014713/page/1